Ambulero

Developer of cell & gene therapies for the treatment of rare vascular disease and critical limb ischemia

placeMiami, Florida, United States calendar_todayFounded 2019 groups5 employees language ambulero.com

Social engagement

Social engagement: 529 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

2 investors on record; lead investors include Orphinic.

Investor typeCountShare
Other / undisclosed2100%

Recent activity

5 Feb 2026
Event
21st American Surgical Congress (Feb. 3-5, 2026 Orlando)
Coming soon